Medicine
Emblaveo 42.3 mg/127 mg per mL powder for injection
Emblaveo 42.3 mg/127 mg per mL powder for injection is a prescription medicine containing Avibactam and Aztreonam for intravenous use, marketed by AbbVie, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in carton until time of use.
Key facts
- Active ingredient (INN)
- Avibactam and Aztreonam
- Brand
- Emblaveo
- Strength
- 42.3 mg/127 mg per mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 10 vials
- Marketing authorisation holder
- AbbVie
- Manufacturer
- AbbVie
- Origin register
- US FDA, United States
- Storage
- Store in carton until time of use.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DF51 Avibactam and Aztreonam
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 February 2025
- Identifiers
- RxCUI 2705355, 2705360DailyMed set ID be1a6c99-d4b3-46d7-9e99-6e5f9fab556aNDC 0074-3878Application NDA217906
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-dose in 1 carton / 12 mL in 1 vial, single-dose | 0074-3878-10 | AbbVie | 7 February 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Avibactam and Aztreonam is a fixed-dose combination of a monobactam antibacterial and a beta lactamase inhibitor indicated in patients 18 years and older, among other approved uses. MedsAcross supplies Avibactam and Aztreonam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Avibactam and AztreonamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EMBLAVEO prescribing information (AbbVie) · U.S. National Library of Medicine, DailyMed
- Emblaveo: European public assessment report (EPAR) · European Medicines Agency
Need Emblaveo 42.3 mg/127 mg per mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.